Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-ASIA-Congress-2022-1000x250-No-Bubbles

ESMO Asia 2022 will be returning to Singapore and also be available online from 2 – 4 December 2022!

This exciting landmark event will bring together oncologists from the region and beyond to present the latest discoveries in medical oncology.

The congress scientific committee comprising of renowned and leading Asian and European experts has developed an extensive programme addressing new developments in the respective fields, as well as updating delegates on the latest standards of care across all major tumour types. The congress will be an important forum for sponsors to engage with Asian prescribers and to present their latest products as well as services both in Singapore and in our virtual congress platform!

Fast Facts: ESMO Asia 2022

  • Expecting up to 4,000 participants
  • 16 Educational and 1 Keynote lecture
  • Multidisciplinary and Challenge your Expert sessions
  • Abstract programme with oral and poster presentations
  • Special sessions including Guidelines/PAGA and initiatives in collaboration with other societies
  • An internationally renowned faculty
  • 20 Industry Satellite Symposia
  • Interactive Virtual Exhibition and On-site Exhibition
  • Numerous networking and engagement opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution of the following organisations in the ESMO Asia Congresses over the years.

Past attendees

  • AbbVie Pte Ltd
  • Accord Healthcare
  • ACE Oncology
  • ACT Genomics
  • Agilent
  • Amgen
  • ArcherDX
  • Asia Genomics
  • Astellas Pharma Inc.
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals, Inc.
  • Beacon Medicare Limited
  • Biocartis
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cancer Expert Now
  • Caris Life Sciences
  • Celgene
  • Clearbridge Health
  • Daiichi Sankyo
  • ECS-Screening
  • Eisai Co. Ltd
  • Elsevier
  • Exelixis Inc.
  • F. Hoffman-La Roche Ltd
  • Ferring Pharmaceuticals
  • Fresenius Kabi Deutschland GmbH
  • Gilead Science Europe Ltd
  • GlaxoSmithKline
  • Guardant Health
  • HalioDx
  • Hetero
  • Human Longevity, Inc.
  • Human Metabolome Technologies​
  • Illumina
  • Invivoscribe, Inc
  • Ipsen
  • Lilly Oncology
  • Lucence Diagnostics
  • Medscape Oncology
  • Merck
  • Merck Pfizer Alliance
  • Molecular Health
  • MSD Pharma (Singapore) Pte Ltd
  • Myriad Genetics
  • NanoString Technologies
  • Natera
  • Novartis
  • Pfizer
  • Pierre Fabre
  • Quark Biosciences
  • Quintiles
  • Roche
  • Sanofi-Aventis Singapore Pte Ltd
  • Servier
  • Singapore Precision Medicine Centre Pte Ltd.
  • Sysmex Asia Pacific
  • Takeda Pharmaceuticals
  • Tessa Therapeutics Pte Ltd
  • Thermo Fisher Scientific
  • Veracyte
  • Xi'an Good Doctor Medical Science and Technology Co. Ltd.
  • Zai Lab (Hong Kong) Limited

How can I participate in ESMO Asia 2022?

Contact the ESMO Asia Events Sponsorship Team for more details and we look forward to hearing from you!

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.